A case-control study was conducted to investigate the role of a familial history of cancer in the etiology of childhood acute leukemia. The history of cancer in the relatives of 472 cases was compared with that of 567 population-based controls. Recruitment was frequency matched on age, sex and region. The familial history of cancer in each child's relatives was reported by the mother in response to a standardized self-administered questionnaire. A familial history of solid tumor in first or second-degree relatives was associated with an increased risk of acute lymphoblastic leukemia (odds ratio (OR) = 1.6 [95% confidence interval, 1.2-2.1]), while a familial history of hematopoietic malignancies in first or second-degree relatives was associated with an increased risk of acute myeloid leukemia (OR = 4.3 [1.4-13]). The ORs for the histories of cancer increased with the number of relatives with cancer (OR = 1.5 [1.1-2.0] for one relative and OR = 2.3 [1.3-3.8] for two relatives or more; P trend < 0.0001). Significant associations between childhood acute leukemia and familial history of genital cancers and brain tumor were also observed (OR = 2.7 [1.2-5.8] and OR = 10.7 [1.3-86], respectively). This study supports the hypothesis that a familial history of cancer may play a role in the etiology of childhood acute leukemia. It also evidences some specific associations that require further investigation.
Introduction
Leukemia is the most common cancer in childhood with an incidence rate of 43.1 per 1 000 000 per year in France (Clavel et al., 2004) . With the exception of ionizing radiation, certain rare genetic syndromes and cancer chemotherapy, its etiology remains largely unknown.
The hypothesis of a relationship between a familial history of cancer and a risk of childhood acute leukemia (AL) was suggested by the reports of familial clusters of leukemia (Gunz et al., 1975) , especially for acute myeloid leukemia (AML) (Gunz et al., 1978; Horwitz et al., 1996) and chronic lymphocytic leukemia (Linet et al., 1989) , and by several case-control studies. To the authors' knowledge, only four case-control studies and five cohort studies have been published to date. A study in the United States by the Children's Oncology Group found a non-significant relationship between AL in children aged less than 18 months and a history of cancer in first-degree relatives (Wen et al., 1998) . A Russian study evidenced an association between AL and a familial history of cancer in relatives of any degree (Smulevich et al., 1994) . A French study also showed a positive and significant association between AL and a history of solid tumor or hematopoietic malignancy in first or second-degree relatives (Perrillat et al., 2001) . Lastly, a Canadian study evidenced an association between acute lymphoblastic leukemia (ALL) and a history of hematopoietic malignancies only, in first or second-degree relatives (Infante-Rivard and Guiguet, 2004) . All four studies reported estimated odds ratios (ORs) between 1.5 and 2. Conversely, cohort studies, based on childhood cancer registries, did not show any increase in leukemia risk in the parents and/or siblings of child cancer patients (Olsen et al., 1995; Falck-Winther et al., 2001; Hemminki and Mutanen, 2001; Brunetti et al., 2003; Couto et al., 2005) . The main objective of the present study was to assess the role of genetic and environmental factors in the etiology of childhood AL. This study investigated the relationship between a familial history of cancer and childhood AL in a population-based case-control study.
Materials and methods

Study population
The cases were identified through the National Registry of Childhood Leukemia and Lymphoma, which has registered all the cases of leukemia in children aged less than 15 years in mainland France since 1990 (Clavel et al., 2004) . All the leukemia cases were confirmed by bone marrow analysis. The eligible cases were all the children whose AL was diagnosed between 1 January 1995 and 31 December 1998, who were aged not more than 15 years, and who were residing in mainland France at the time of diagnosis. The cases from four regions already involved in a hospital-based case-control study (Perrillat et al., 2001) and those from four other regions whose oncology departments were unable to contribute to the study for practical reasons were excluded. Out of the 651 eligible cases, 472 (73%) were included in the study.
The controls were randomly selected from the general population using a sample of 30 000 phone numbers representative of the French population with respect to area of residence and municipality size category. The controls were frequency matched with the cases on the basis of age at diagnosis, sex and region. Out of the 805 eligible controls, 567 (70%) were included in the study.
Data collection
The case and control mothers answered a standardized self-administered questionnaire, given to them by the child's physician for cases, and sent to them by mail, with their agreement, for controls.
The questionnaire elicited information on socio-demographic characteristics, the occupational history of the parents, parental smoking habits, maternal alcohol and coffee consumption during pregnancy, familial history of cancer and the medical history of the index child.
The familial history of cancer was collected for the first (siblings and parents) and second (grandparents, uncles, aunts, half brothers and sisters)-degree relatives of the index child. For each relative with a history of cancer, the mother reported the specific type of cancer, the age at diagnosis and the kinship with the index child. The type of cancer was coded using the International Classification of Diseases, ninth revision.
Study power
With a power of 80% and a = 5%, the size of the study enables detection of minimum ORs of 1.5, 1.7 and 2.0 for exposure prevalences among controls of 30, 10 and 5%, respectively.
Statistical analysis
All the analyses were performed using the SAS software package (version 8.1, Cary, North Carolina, USA). Statistical analyses were performed using unconditional logistic regression models including the stratification variables (age, sex and region). Family size was systematically included in the regression models. Separate analyses and polytomous regressions were also used to estimate specific ORs for ALL and AML. Adjustments for potential socio-demographic confounders were also incorporated in the various analyses.
Results
Out of the 472 cases, 407 had a diagnosis of ALL, 62 had a diagnosis of AML and three consisted of unspecified leukemia.
The cases and controls were very similar with regard to age, sex, region of residence at diagnosis, parental education and socio-professional category (Table 1) . Forty-eight percent of the cases and 45% of the controls were in the age group of 2-6 years, corresponding to the incidence peak of leukemia.
A small but significant difference was observed between cases and controls with regard to the total number of family members (12.5 members on average for the controls vs. 13.3 members for the cases; P = 0.001) ( Table 2 ). The cases and controls, however, were similar for the ages of the first-degree relatives, parents and siblings at the time of the child's birth.
Twelve mothers reported a personal history of cancer (three cases of breast cancer, four of uterine cancer, one of ovarian cancer, one of thyroid cancer, one of lung cancer and two of cancer at other sites). Among the fathers, 13 had a personal history of cancer (three cases of thyroid cancer, one of pancreas cancer, one of liver cancer, one of brain tumor, one of kidney cancer, one of melanoma, one of bone tumor, one of stomach tumor and three of hematopoietic malignancies). Only one case had a sibling with cancer (osteosarcoma). Table 3 , AL was significantly associated with a history of solid tumor with an OR of 4.1 [95% confidence interval, 1.5-11.6] for the first-degree relatives and an OR of 1.5 [1.1-1.9] for the second-degree relatives. A non-significant excess of hematopoietic malignancies was found among the relatives of the cases, compared with the controls (OR = 1.6 [0.8-3.4]).
As shown in
The ORs for the histories of cancer, solid tumors or hematopoietic malignancies, increased with the number of relatives with cancer (OR = 1.5 [1.1-2.0] for one relative and OR = 2.3 [1.3-3.8] for two relatives or more; P trend < 0.0001). The associations were similar for maternal and paternal relatives.
The association with a familial history of solid tumor, for relatives of both degrees, were similar for ALL and AML, but non-significant for AML (Table 4 ). Only AML was positively and significantly associated with a history of hematopoietic malignancy, for both first and seconddegree relatives.
Significant associations between childhood AL and a familial history of genital cancer and brain tumor were observed (OR = 2.7 [1.2-5.8] and OR = 10.7 [1.3-86], respectively). Colonic/rectal and genital tumors were significantly more frequent in relatives of AML cases (OR = 3.9 [1.1-13] and OR = 4.2 [1.3-14], respectively), while lip/mouth and brain tumors were significantly more frequent in the relatives of ALL cases (OR = 3.5 [1.2-10] and OR = 11.5 [1.3-91], respectively). Among the children with more than one relative with cancer, no specific cancer aggregation was observed.
The inclusion of birth order and history of early common infection, previously found to be associated with leukemia in this study (Jourdan-Da Silva et al., 2004) , did not modify the results.
Similar findings were obtained after the exclusion of 12 children with Down's syndrome (10 cases and two controls).
Discussion
A familial history of cancer in first or second-degree relatives was associated with childhood AL with an OR of 1.6 [1.2-2.1]. The ORs increased with the number of relatives with cancer, in a similar manner for maternal and paternal relatives. A familial history of hematopoietic malignancies was only observed for AML (OR = 4.3 [1.4-13]).
The study was able to detect a minimum OR of 2.4 for exposures with 3% prevalence for a history of hematopoietic malignancies and 1.3 for a familial history of cancer, for relatives of both degrees, for all AL. The study may therefore have suffered from a lack of power with respect to the study of hematopoietic malignancies in relatives. The prevalence of cancer -especially hematopoietic malignancies -in the first and second-degree relatives (0.5 and 2%, respectively) was very low, in part owing to the fact that the parents were young.
All the cases were selected from the National Registry of Childhood Leukemia and Lymphoma (NCRL), which has an exhaustiveness of 99% (Clavel et al., 2004) . Thus, a selection bias related to the case identification process seems unlikely.
The response rates for the cases and controls were very similar (73% for the cases and 70% for the controls) and the non-respondent controls did not differ from the respondent controls in terms of age, sex or region of residence. Moreover, the non-respondent and respondent cases also did not differ in terms of age, sex or type of leukemia. Nevertheless, a difference between the respondents and non-respondents in terms of the number of relatives having had cancer could be possible. Case mothers with several relatives with cancer may have had a higher response rate. In order to explain the study findings, however, the non-respondents would have had to have no familial history of cancer, which is very unlikely.
Using the vital status data from the NCRL, the cases who died after their inclusion in the study were compared with the survivors. No difference was observed with respect to familial history of cancer. A survival bias therefore seems unlikely. The cases and controls were comparable in terms of their socio-demographic characteristics and parental age. The size of the family was slightly smaller for the controls than for the cases and all the analyses were therefore adjusted on the size of the family. The results, however, were unchanged.
Differential misclassification of cancer history in firstdegree relatives, over-declaration by case mothers and under-declaration by control mothers are unlikely as the medical histories in question are those of the mother herself, her child's father and her children. Such bias cannot be ruled out for the history of cancer in seconddegree relatives. The prevalence of cancer in the family members of the control group, however, was similar to that in the authors' hospital-based case-control study (Perrillat et al., 2001) . Nevertheless, non-differential misclassifications could not be ruled out.
The results remained unchanged when potential confounding factors were taken into account. Exclusion of children with Down's syndrome did not modify the results. They were also unchanged after adjustment for birth order and early common infections that had previously been found to be associated with AL in the study (Jourdan-Da Silva et al., 2004) .
Only a few case-control studies have investigated the association between childhood AL and a familial history of cancer. An American case-control study, conducted on infants aged less than 18 months found a non-significant positive association between AML and a history of cancer in first-degree relatives (Wen et al., 1998) . This study suffered from lack of power because of the very young age of the children's relatives. The study conducted by Smulevich et al. (1994) evidenced an association between AL and a familial history of cancer for relatives of all degrees. In France, Perrillat et al. (2001) obtained similar results with, in particular, associations with a history of colonic and rectal cancer, melanoma and genital cancer. In that study, a history of hematopoietic malignancy was associated with both ALL and AML. Lastly, in Canada, Infante-Rivard and Guiguet (2004) observed a relationship between a history of hematopoietic malignancy in second-degree relatives and ALL.
Several cohort studies based on childhood cancer registries found no excess of cancer in the parents and/ or siblings of leukemia cases under the age of 15 years (Olsen et al., 1995; Falck-Winther et al., 2001; Hemminki and Mutanen, 2001; Brunetti et al., 2003; Couto et al., 2005) . The results of the various studies are not consistent: case-control studies most often evidenced an association between AL and a family history of cancer while cohort studies did not. The present case-control study, which was large and population-based and based on the French National Registry of Childhood Leukemia and Lymphoma, found similar associations without obvious bias. The results of this study therefore support the hypothesis that a familial history of cancer may play a role in the etiology of childhood AL and suggest the potential responsibility of genetic factors. The results, however, are also compatible with the existence of environmental and/or infectious factors shared by the index child and his/her relatives, especially for the associations observed with first-degree relatives.
